Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Ormsby, Christopher E ^a   SenGupta, Devi ^b   Tandon, Ravi ^b   Deeks, Steven G ^c   Martin, Jeffrey N ^b   Jones, R Brad ^d   Ostrowski, Mario A ^d   Garrison, Keith E ^b   Vázquez Pérez, Joel A ^a   Reyes Terán, Gustavo ^a   Nixon, Douglas F ^b  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENDOGENOUS RETROVIRUS; ENVELOPE GENE; FEMALE; GROUP SPECIFIC ANTIGEN GENE; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOSTIMULATION; IN VIVO STUDY; MALE; VIRUS ACTIVATION; VIRUS EXPRESSION; VIRUS GENE; VIRUS TRANSMISSION;

ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DEMOGRAPHY; ENDOGENOUS RETROVIRUSES; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY; MALE; MIDDLE AGED; RNA, VIRAL;

HUMAN ENDOGENOUS RETROVIRUS; HUMAN ENDOGENOUS RETROVIRUSES; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84864686306     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041021     Document Type: Article

References (56)

1. Tsibris AMN, Hirsch MS, (2010) Antiretroviral therapy in the clinic. J Virol 84: 5458-5464 doi:10.1128/JVI.02524-09.
2. Deeks SG, Kitchen CMR, Liu L, Guo H, Gascon R, et al. (2004) Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104: 942-947 doi:10.1182/blood-2003-09-3333.
3. Giorgi JV, Lyles RH, Matud JL, Yamashita TE, Mellors JW, et al. (2002) Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr 29: 346-355.
4. Hunt PW, Cao HL, Muzoora C, Ssewanyana I, Bennett J, et al. (2011) Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS 25: 2123-2131 doi:10.1097/QAD.0b013e32834c4ac1.
5. Murray SM, Down CM, Boulware DR, Stauffer WM, Cavert WP, et al. (2010) Reduction of immune activation with chloroquine therapy during chronic HIV infection. J Virol 84: 12082-12086 doi:10.1128/JVI.01466-10.
6. McCune JM, Hanley MB, Cesar D, Halvorsen R, Hoh R, et al. (2000) Factors influencing T-cell turnover in HIV-1-seropositive patients. J Clin Invest 105: R1-8 doi:10.1172/JCI8647.
7. Weissman D, Barker TD, Fauci AS, (1996) The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation. J Exp Med 183: 687-692.
8. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, et al. (2008) Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 197: 126-133 doi:10.1086/524143.
9. Nakanjako D, Ssewanyana I, Mayanja-Kizza H, Kiragga A, Colebunders R, et al. (2011) High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort. BMC Infect Dis 11: 43 doi:10.1186/1471-2334-11-43.
10. Estes JD, Gordon SN, Zeng M, Chahroudi AM, Dunham RM, et al. (2008) Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques. J Immunol 180: 6798-6807.
11. Rodríguez-García M, Porichis F, de Jong OG, Levi K, Diefenbach TJ, et al. (2011) Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10. J Leukoc Biol 89: 507-515 doi:10.1189/jlb.0610327.
12. Arens R, Baars PA, Jak M, Tesselaar K, van der Valk M, et al. (2005) Cutting edge: CD95 maintains effector T cell homeostasis in chronic immune activation. J Immunol 174: 5915-5920.
13. Chehimi J, Azzoni L, Farabaugh M, Creer SA, Tomescu C, et al. (2007) Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment. J Immunol 179: 2642-2650.
14. Miedema F, Petit AJ, Terpstra FG, Schattenkerk JK, de Wolf F, et al. (1988) Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest 82: 1908-1914 doi:10.1172/JCI113809.
15. Espinosa E, Ormsby CE, Reyes-Teran G, Asaad R, Sieg SF, et al. (2010) Dissociation of CD154 and cytokine expression patterns in CD38+ CD4+ memory T cells in chronic HIV-1 infection. J Acquir Immune Defic Syndr 55: 439-445 doi:10.1097/QAI.0b013e3181ef991d.
16. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, et al. (2003) T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 187: 1534-1543 doi:10.1086/374786.
17. Deeks SG, Phillips AN, (2009) HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 338: a3172.
18. Douek D, (2007) HIV disease progression: immune activation, microbes, and a leaky gut. Top HIV Med 15: 114-117.
19. Paiardini M, Frank I, Pandrea I, Apetrei C, Silvestri G, (2008) Mucosal immune dysfunction in AIDS pathogenesis. AIDS Rev 10: 36-46.
20. Doisne J-M, Urrutia A, Lacabaratz-Porret C, Goujard C, Meyer L, et al. (2004) CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. J Immunol 173: 2410-2418.
21. Compston LI, Li C, Sarkodie F, Owusu-Ofori S, Opare-Sem O, et al. (2009) Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa. J Med Virol 81: 1860-1868 doi:10.1002/jmv.21614.
22. Gasser O, Bihl F, Sanghavi S, Rinaldo C, Rowe D, et al. (2009) Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation. Am J Transplant 9: 794-803 doi:10.1111/j.1600-6143.2008.02539.x.
23. Butz EA, Bevan MJ, (1998) Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 8: 167-175.
24. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921 doi:10.1038/35057062.
25. Villesen P, Aagaard L, Wiuf C, Pedersen FS, (2004) Identification of endogenous retroviral reading frames in the human genome. Retrovirology 1: 32 doi:10.1186/1742-4690-1-32.
26. Jern P, Sperber GO, Blomberg J, (2005) Use of endogenous retroviral sequences (ERVs) and structural markers for retroviral phylogenetic inference and taxonomy. Retrovirology 2: 50 doi:10.1186/1742-4690-2-50.
27. Christensen T, (2010) HERVs in neuropathogenesis. J Neuroimmune Pharmacol 5: 326-335 doi:10.1007/s11481-010-9214-y.
28. Freimanis G, Hooley P, Ejtehadi HD, Ali HA, Veitch A, et al. (2010) A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis. Clin Exp Immunol 160: 340-347 doi:10.1111/j.1365-2249.2010.04110.x.
29. Romanish MT, Cohen CJ, Mager DL, (2010) Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer. Semin Cancer Biol 20: 246-253 doi:10.1016/j.semcancer.2010.05.005.
30. Huang W, Li S, Hu Y, Yu H, Luo F, et al. (2010) Implication of the env Gene of the Human Endogenous Retrovirus W Family in the Expression of BDNF and DRD3 and Development of Recent-Onset Schizophrenia. Schizophr Bull. Available: http://www.ncbi.nlm.nih.gov/pubmed/20100784. Accessed 30 January 2011.
31. Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y, (2006) Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. AIDS Res Hum Retroviruses 22: 979-984 doi:10.1089/aid.2006.22.979.
32. Nellåker C, Yao Y, Jones-Brando L, Mallet F, Yolken RH, et al. (2006) Transactivation of elements in the human endogenous retrovirus W family by viral infection. Retrovirology 3: 44 doi:10.1186/1742-4690-3-44.
33. Ramos-Lopez E, Ghebru S, Van Autreve J, Aminkeng F, Herwig J, et al. (2006) Neither an intronic CA repeat within the CD48 gene nor the HERV-K18 polymorphisms are associated with type 1 diabetes. Tissue Antigens 68: 147-152 doi:10.1111/j.1399-0039.2006.00637.x.
34. Subramanian RP, Wildschutte JH, Russo C, Coffin JM, (2011) Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology 8: 90 doi:10.1186/1742-4690-8-90.
35. Löwer R, Löwer J, Kurth R, (1996) The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci USA 93: 5177-5184.
36. Contreras-Galindo R, López P, Vélez R, Yamamura Y, (2007) HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Hum Retroviruses 23: 116-122 doi:10.1089/aid.2006.0117.
37. Contreras-Galindo RA, Kaplan MH, Contreras-Galindo AC, Gonzalez-Hernandez M, Ferlengui I, et al. (2011) Characterization of Human Endogenous Retroviral Elements in the Blood of HIV-1-Infected Individuals. Journal of Virology. Available: http://www.ncbi.nlm.nih.gov/pubmed/22031938. Accessed 5 December 2011.
38. Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, et al. (2007) T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog 3: e165 doi:10.1371/journal.ppat.0030165.
39. SenGupta D, Tandon R, Vieira RGS, Ndhlovu LC, Lown-Hecht R, et al. (2011) Strong Human Endogenous Retrovirus-Specific T Cell Responses Are Associated with Control of HIV-1 in Chronic Infection. J Virol 85: 6977-6985 doi:10.1128/JVI.00179-11.
40. van der Kuyl AC, (2012) HIV infection and HERV expression: a review. Retrovirology 9: 6 doi:10.1186/1742-4690-9-6.
41. Dunn HS, Haney DJ, Ghanekar SA, Stepick-Biek P, Lewis DB, et al. (2002) Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. J Infect Dis 186: 15-22 doi:10.1086/341079.
42. Akira S, Hemmi H, (2003) Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85: 85-95.
43. World Health Organization (2006) WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children.
44. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 25: 402-408 doi:10.1006/meth.2001.1262.
45. Rowe HM, Trono D, (2011) Dynamic control of endogenous retroviruses during development. Virology 411: 273-287 doi:10.1016/j.virol.2010.12.007.
46. Esnault C, Priet S, Ribet D, Heidmann O, Heidmann T, (2008) Restriction by APOBEC3 proteins of endogenous retroviruses with an extracellular life cycle: ex vivo effects and in vivo "traces" on the murine IAPE and human HERV-K elements. Retrovirology 5: 75 doi:10.1186/1742-4690-5-75.
47. Tönjes RR, Löwer R, Boller K, Denner J, Hasenmaier B, et al. (1996) HERV-K: the biologically most active human endogenous retrovirus family. J Acquir Immune Defic Syndr Hum Retrovirol 13 Suppl 1: S261-267.
48. Chen DY, Balamurugan A, Ng HL, Yang OO, (2011) Antiviral Activity of Human Immunodeficiency Virus Type 1 Gag-Specific Cytotoxic T Lymphocyte Targeting Is Not Necessarily Intrinsically Superior to Envelope Targeting. J Virol 85: 2474-2478 doi:10.1128/JVI.01726-10.
49. Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, et al. (2011) Immunodominance of HIV-1 Specific CD8+ T-Cell Responses Is Related to Disease Progression Rate in Vertically Infected Adolescents. PLoS ONE 6: e21135 doi:10.1371/journal.pone.0021135.
50. Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, et al. (1996) Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol 156: 2616-2623.
51. Vázquez-Pérez JA, Ormsby CE, Hernández-Juan R, Torres KJ, Reyes-Teran G, (2009) APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression. Retrovirology 6: 23 doi:10.1186/1742-4690-6-23.
52. Frank O, Verbeke C, Schwarz N, Mayer J, Fabarius A, et al. (2008) Variable transcriptional activity of endogenous retroviruses in human breast cancer. J Virol 82: 1808-1818 doi:10.1128/JVI.02115-07.
53. Stauffer Y, Theiler G, Sperisen P, Lebedev Y, Jongeneel CV, (2004) Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues. Cancer Immun 4: 2.
54. Li F, Nellåker C, Yolken RH, Karlsson H, (2011) A systematic evaluation of expression of HERV-W elements; influence of genomic context, viral structure and orientation. BMC Genomics 12: 22 doi:10.1186/1471-2164-12-22.
55. Punkosdy GA, Blain M, Glass DD, Lozano MM, O'Mara L, et al. (2011) Regulatory T-cell expansion during chronic viral infection is dependent on endogenous retroviral superantigens. Proc Natl Acad Sci USA 108: 3677-3682 doi:10.1073/pnas.1100213108.
56. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, et al. (2003) T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 187: 1534-1543 doi:10.1086/374786.